FDA approval adds new life to Copaxone

29-01-2014

FDA approval adds new life to Copaxone

On January 28, Teva announced that the US Food and Drug Administration (FDA) had approved its supplemental new drug application for a new formulation of its biggest selling drug Copaxone.


Copaxone, Teva, FDA, dosage, dosage patent

More on this story

Teva to lose grip on Copaxone next year
20-11-2013

LSIPR